The Lancet Global Health
-
1
[Articles] WHO estimates of the global, regional, and national burden of 42 foodborne infectious and chemical hazards, 2000–21: an updated data synthesis
-
2
[Comment] Including female genital mutilation or cutting in the WHO Adverse Childhood Experiences International Questionnaire: the case and the barriers
-
3
[Correspondence] Health data poverty in low-income and middle-income countries: a challenge for climate justice
-
4
[Comment] Mexico’s Servicio Universal de Salud: a pathway to integration and universal health coverage?
-
5
[Correspondence] Population representativeness and interviewer-level heterogeneity in the Gaza Mortality Survey
-
6
[Correspondence] Response to DellaPergola and Zlochin
-
7
[Articles] WHO estimates of the global, regional, and national burden of eight foodborne non-diarrhoeal enteric disease hazards, 2000–21: an updated data synthesis
-
8
[Articles] WHO estimates of the global, regional, and national burden of 14 foodborne diarrhoeal enteric hazards, 2000–21: an updated data synthesis
-
9
[Comment] WHO foodborne disease estimates 2000–21: bridging the burdens of infectious and non-communicable diseases
-
10
[Articles] WHO estimates of the global, regional, and national disease burden of nine foodborne chemicals, 2000–21: an updated data synthesis
The Lancet Haematology
-
1
[In Focus] Reproductive health in Ireland: moving forward as others roll back
-
2
[In Focus] Living with a bleeding disorder as a woman
-
3
[In Focus] Menstruation in Nepal: tradition, stigma, and transition
-
4
[Articles] Haematopoietic stem cell transplantation in hepatosplenic T-cell lymphoma: a retrospective analysis of the EBMT Lymphoma Working Party
-
5
[Editorial] Beyond maximum grade: a decade in the making
-
6
[Comment] Beyond maximum grade: making toxicity count
-
7
[Correspondence] FAIR(er) treatment of non-anaemic iron deficiency during pregnancy: clarifying the evidence – Authors' reply
-
8
[News] ISTH 2026 Congress
-
9
[Articles] Epcoritamab with rituximab and lenalidomide as first-line treatment for follicular lymphoma (EPCORE NHL-2): an open-label, multicentre, phase 1/2 b trial
-
10
[News] Building stronger blood systems
The Lancet Healthy Longevity
-
1
[Editorial] Ending preventable heat-related deaths among older adults
-
2
[Personal View] Falls resilience framework: advancing from risk reduction to resilience building in older adults
-
3
[Comment] Adjunctive metformin for obesity and frailty in older people—puncturing inflated expectations?
-
4
[Articles] Metformin added to lifestyle intervention for physical function in older adults with obesity (DEMFOS trial): a randomised controlled trial
-
5
[Articles] Incidence of dementia after age 90 years and association with APOE genotype, race, and sex in the USA: the LifeAfter90 prospective cohort study
-
6
[Review] Effectiveness of dyadic interventions in improving outcomes for adults with multiple long-term conditions or frailty and their informal carers: a systematic review
-
7
[Comment] Statin discontinuation in older adults: changing the conversation, not the default
-
8
[Articles] Discontinuation of statins for primary prevention of atherosclerotic cardiovascular disease in adults aged 75 years or older (SAGA/SITE): a multicentre, open-label, pragmatic, non-inferiority randomised trial
-
9
[Comment] Revisiting relationships between APOE and dementia incidence in people aged 90 years and older
-
10
[Articles] Cognitive behavioural therapy for insomnia and epigenetic ageing: secondary analysis from a randomised controlled trial
The Lancet HIV
-
1
[Editorial] Will the new UN political declaration deliver?
-
2
[Correspondence] Occupational HIV monitoring should match standard of care
-
3
[Articles] Cost-effectiveness of emergency department opt-out testing for HIV in England: a modelling study
-
4
[Comment] Achieving 95-95-95 outcomes: it takes a couple
-
5
[Articles] Effectiveness of interventions to promote couples-based HIV testing and family health during pregnancy and postpartum in Kenya: a multicentre, couples-based, randomised controlled trial
-
6
[Comment] Invisible populations: SOGI data and HIV drug safety
-
7
[Articles] HIV acquisitions, safety, and pharmacokinetics of lenacapavir for HIV pre-exposure prophylaxis in pregnant and lactating women (PURPOSE 1): a substudy of a phase 3, randomised controlled trial
-
8
[Viewpoint] Does U=U apply during breastfeeding? An urgent research priority
-
9
[Articles] Interventions to improve viral suppression and adherence to antiretroviral therapy among people living with HIV: a systematic review and network meta-analysis
-
10
[Review] Evolving understanding of Kaposi sarcoma and associated diseases in the ART era
The Lancet Infectious Diseases
-
1
[Newsdesk] Research in brief
-
2
[Profile] Aalisha Sahukhan—strengthening public health responses
-
3
[Obituary] Clarence James Peters
-
4
[Editorial] Oral carbapenem—a double-edged sword?
-
5
[Clinical Picture] Tularaemia after deer exposure in a vehicular collision
-
6
[Correspondence] Seasonal influenza versus COVID-19 hospitalisation risk during the 2025–26 influenza season
-
7
[Correspondence] Diagnostic performance of RADIONE for diagnosis of BDBV
-
8
[Correspondence] Real-time epidemic intelligence in a public health emergency: the 2026 Bundibugyo virus outbreak
-
9
[Corrections] Correction to Lancet Infect Dis 2020; 20: 60–79
-
10
[Corrections] Correction to Lancet Infect Dis 2020; 20: 37–59
The Lancet Microbe
-
1
[Correspondence] Rethinking airborne transmission risk of monkeypox virus: a methodological perspective on quantitative PCR threshold collapse in environmental air sampling
-
2
[Articles] Evaluation of the effectiveness of artemether–lumefantrine and artesunate–pyronaridine each combined with single low-dose primaquine in adults with Plasmodium falciparum infection in Ethiopia: a phase 2/3, observer-masked, randomised, parallel-
-
3
[Articles] Efficacy of chloroquine plus low-dose primaquine and pyronaridine–artesunate plus low-dose primaquine against Plasmodium vivax malaria in adults and transmission to mosquitoes in Ethiopia: a phase 2/3, observer-masked, randomised, parallel-grou
-
4
[Articles] Widespread circulation of Alongshan virus in Austria and serological evidence for infection in humans: a nationwide molecular and serological observational study
-
5
[Comment] Genotype-based antimicrobial resistance tests need a new regulatory framework
-
6
[Articles] Wastewater-based sequencing of respiratory syncytial virus to investigate lineage dynamics and antigenic site mutations: a retrospective genomic epidemiology study
-
7
[Articles] Comparison of phylogenetic metrics of transmission between symptomatic and asymptomatic tuberculosis in individuals who were incarcerated in Brazil in 2008–24: a retrospective genomic epidemiology study
-
8
[Articles] Multidimensional prophage profiling of carbapenem-resistant Enterobacteriaceae in Thailand: a nationwide, multicentre, genomic study
-
9
[Comment] Transmission dynamics of Andes virus and implications for outbreak monitoring
-
10
[Articles] Assessment of dried blood spot and umbilical cord blood samples for the quantification of maternally transferred IgG against the group B streptococcal alpha-like surface proteins in neonates at Kolding Hospital, Denmark: a proof-of-concept, cro
The Lancet Neurology
-
1
[Comment] Advancing migraine prevention with comparative evidence
-
2
[Articles] Tolerability, safety, and efficacy of atogepant versus topiramate in adults with migraine (TEMPLE): a randomised, head-to-head, phase 3b trial
-
3
[In Context] Michael Schöll
-
4
[In Context] A unified evolutionary explanation of Parkinson's disease
-
5
[In Context] A little less conversation, a little more action
-
6
[Articles] Safety and efficacy of guanabenz in early-childhood onset vanishing white matter: primary analysis of a single-arm, phase 1/2 trial
-
7
[In Context] Music: a key component of brain health
-
8
[Articles] Antiseizure medication use in pregnancy and the risk of poor fetal growth in the EURAP international registry: a prospective cohort study
-
9
[Articles] Intensive blood pressure lowering after spontaneous intracerebral haemorrhage for secondary stroke prevention (RECAP-ICH): a systematic review and individual participant data meta-analysis
-
10
[Editorial] Epilepsy care must look beyond seizure control
The Lancet Oncology
-
1
[Articles] Chemoradiotherapy versus short-course radiotherapy for response-adapted organ preservation in early-stage and intermediate-stage rectal cancer (STAR-TREC): 12-month results of an international, multicentre, open-label, parallel-group, randomise
-
2
[Comment] STAR-TREC and TESAR trials: strengthening the evidence for organ preservation in rectal cancer
-
3
[Articles] Ivonescimab plus chemotherapy versus placebo plus chemotherapy in patients with advanced EGFR-mutated non-small-cell lung cancer after disease progression on EGFR tyrosine kinase inhibitor therapy (HARMONi): a multicentre, randomised, double-bl
-
4
[Review] Tumour-infiltrating lymphocytes and breast radiotherapy: perspectives from the International Immuno-Oncology Biomarker Working Group
-
5
[Articles] Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study
-
6
[Articles] Manual, digital, and AI tumour-infiltrating lymphocyte scoring: a secondary analysis of the APHINITY randomised trial
-
7
[Articles] High-dose radiotherapy in patients with high-risk prostate cancers treated with long-term androgen deprivation therapy (GETUG AFU 18): a randomised, phase 3 trial
-
8
[Perspectives] Rethinking failure and tolerance in oncology
-
9
[Articles] SHR-A2102, a nectin-4 directed antibody–drug conjugate, in patients with pretreated advanced solid tumours: a multicentre, single-arm, phase 1 trial
-
10
[Articles] Ifebemtinib plus garsorasib in previously treated metastatic colorectal cancer with KRASG12C mutation: a multicentre, randomised, phase 1b/2 trial
The Lancet Planetary Health
-
1
[Editorial] Biodiversity: actions lagging behind aspirations
-
2
[Newsdesk] Planetary Health Research Digest
-
3
[Comment] Health and plastics: avenues for strengthening the plastics treaty
-
4
[Corrections] Correction to Lancet Planet Health 2026, 10: 101423
-
5
[Personal View] Wellbeing for people and the planet: how to value everyone and everything on a thriving planet beyond 2030
-
6
[Review] Prices and cost drivers of alternatives to animal-source foods: a scoping review and narrative analysis
-
7
[Articles] Pandemic impacts on protected rainforests and rural communities with variable health and livelihood support in West Kalimantan, Indonesia: a mixed-methods approach combining household surveys and remote sensing
-
8
[Articles] Drivers of sylvatic yellow fever transmission in southeast Brazil: a joint epidemiological and phylodynamic inference
-
9
[Articles] Environmental suitability of Coccidioides in the USA under climate change scenarios: a modelling study
-
10
[Review] Climate change and malaria in west Africa: a review of strategies to handle one of the world’s most prominent anthroponoses